Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Biological therapy boosts the immune system to effectively fight melanoma.

A 5 cm hair sample can reveal blood type and keratin type for forensic use.

Machine learning can help find new ways to treat alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Selective breeding can enhance immunity in dairy cattle.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Six months after COVID-19, most patients still had autoantibodies.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Fetal skin biopsy can help diagnose protein-related disorders before birth.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.